Neutralizing monoclonal antibodies to different clades of Influenza A H5N1 viruses

Journal of Virological Methods

Volumn 157, Issue 2, 2009, Pages 161-167

  Oh, Sawyin ^a   Selleck, Paul ^c   Temperton, Nigel J ^d   Chan, Paul K S ^e   Capecchi, Barbara ^f   Manavis, Jim ^a   Higgins, Geoff ^a   Burrell, Christopher J ^a,b   Kok, Tuckweng ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c CSIRO   (Australia)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^f NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

H5N1; Haemagglutinin; Influenza; Monoclonal antibodies; Neutralization; Pseudotype

Indexed keywords

ANTIGEN; EPITOPE; HEMAGGLUTININ; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; REAGENT;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CELL STRAIN; CLADISTICS; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HONG KONG; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; INFLUENZA VIRUS A H5N1; NONHUMAN; PRIORITY JOURNAL; PSEUDOTYPING; RETROVIRUS; SENSITIVITY AND SPECIFICITY; THAILAND; VIRUS NEUTRALIZATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CHICKENS; CROSS REACTIONS; HEMAGGLUTININS, VIRAL; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H5N1 SUBTYPE; INHIBITORY CONCENTRATION 50; NEUTRALIZATION TESTS;

EID: 63449085469     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.12.016     Document Type: Article

References (36)

1. Brown L.E., Murray J.M., White D.O., and Jackson D.C. An analysis of the properties of monoclonal antibodies directed to epitopes on influenza virus hemagglutinin. Arch. Virol. 114 (1990) 1-26
2. Capecchi, B., Fasolo, A., Alberini, I., Baudner, B., Crotta, S., Temperton, N.J., Montomoli, E., Del Giudice, G., Rappuoli, R., 2007. Use of Pseudotyped Particles Expressing Influenza A/VietNam/1194/2004 Hemagglutinin in Neutralization Assays. In: J.M. Katz (Ed), Options for the Control of Influenza VI, International Medical Press, ISBN: 978-1-901-769-16-6, Toronto, Canada, pp. 303-305.
3. Chen H., Smith G.J., Zhang S.Y., Qin K., Wang J., Li K.S., Webster R.G., Peiris J.S., and Guan Y. Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 436 (2005) 191-192
4. de Jong J.C., Claas E.C., Osterhaus A.D., Webster R.G., and Lim W.L. A pandemic warning?. Nature 389 (1997) 554
5. Dimmock N.J. Neutralization of animal viruses. Curr. Top. Microbiol. Immunol. 183 (1993) 1-149
6. Gubareva L.V., and Hayden F.G. M2 and Neuraminidase Inhibitors: Anti-influenza Activity, Mechanisms of Resistance and Clinical Effectiveness (2006), Caister Academic Press, Norfolk, NR, England
7. Ha Y., Stevens D.J., Skehel J.J., and Wiley D.C. H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes. EMBO J. 21 (2002) 865-875
8. Hanson B.J., Boon A.C., Lim A.P., Webb A., Ooi E.E., and Webby R.J. Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for Influenza A H5 hemagglutinin in mice. Respir. Res. 7 (2006) 126
9. He Q., Velumani S., Du Q., Lim C.W., Ng F.K., Donis R., and Kwang J. Detection of H5 avian influenza viruses by antigen-capture enzyme-linked immunosorbent assay using H5-specific monoclonal antibody. Clin. Vaccine Immunol. 14 (2007) 617-623
10. Huang H., Dan H., Zhou Y., Yu Z., Fan H., Tong T., Jin M., and Chen H. Different neutralization efficiency of neutralizing monoclonal antibodies against avian influenza H5N1 virus to virus strains from different hosts. Mol. Immunol. 44 (2007) 1052-1055
11. International Atomic Energy Agency, 1973. The manual on radiation sterilization of medical and biological. The Technical Reports Series (Vienna). pp. 62-63.
12. Kandun I.N., Wibisono H., Sedyaningsih E.R., Yusharmen, Hadisoedarsuno W., Purba W., Santoso H., Septiawati C., Tresnaningsih E., Heriyanto B., Yuwono D., Harun S., Soeroso S., Giriputra S., Blair P.J., Jeremijenko A., Kosasih H., Putnam S.D., Samaan G., Silitonga M., Chan K.H., Poon L.L., Lim W., Klimov A., Lindstrom S., Guan Y., Donis R., Katz J., Cox N., Peiris M., and Uyeki T.M. Three Indonesian clusters of H5N1 virus infection in 2005. N. Engl. J. Med. 355 (2006) 2186-2194
13. Kaverin N.V., Rudneva I.A., Govorkova E.A., Timofeeva T.A., Shilov A.A., Kochergin-Nikitsky K.S., Krylov P.S., and Webster R.G. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J. Virol. 81 (2007) 12911-12917 (Epub 2007 September 19)
14. Kok T., Mickan L.D., and Burrell C.J. Routine diagnosis of seven respiratory viruses and Mycoplasma pneumoniae by enzyme immunoassay. J. Virol. Methods 50 (1994) 87-100
15. Kolokoltsov A.A., Weaver S.C., and Davey R.A. Efficient functional pseudotyping of oncoretroviral and lentiviral vectors by Venezuelan equine encephalitis virus envelope proteins. J. Virol. 79 (2005) 756-763
16. Kong W.-p., Hood C., Yang Z.-y., Wei C.-J., Xu L., Garcia-Sastre A., Tumpey T.M., and Nabel G.J. Protective immunity to lethal challenge of the 1918 pandemic influenza virus by vaccination. Proc. Natl. Acad. Sci. 103 (2006) 15987-15991
17. Lam T.T., Hon C.C., Pybus O.G., Kosakovsky Pond S.L., Wong R.T., Yip C.W., Zeng F., and Leung F.C. Evolutionary and transmission dynamics of reassortant H5N1 influenza virus in Indonesia. PLoS Pathog. 4 (2008) e1000130
18. Lamb R., and Krug R.M. Orthomyxoviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology vol. 1 (2001), Lippincott Williams & Wilkins, Philadelphia 1487-1531
19. Laver G. Influenza drug could abort a pandemic. Nature 434 (2005) 821
20. Lennette E.H., and Schmidt N.J. Diagnostic Procedures for: Viral Rickettsial and Chlamydial Infections (1979), American Public Health Association, Inc., Washington, DC p. 20005
21. Marasco W.A., and Sui J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat. Biotechnol. 25 (2007) 1421-1434
22. Mullbacher A., Ada G.L., and Hla R.T. Gamma-irradiated Influenza A virus can prime for a cross-reactive and cross-protective immune response against Influenza A viruses. Immunol. Cell Biol. 66 Pt 2 (1988) 153-157
23. Nefkens I., Garcia J.M., Ling C.S., Lagarde N., Nicholls J., Tang D.J., Peiris M., Buchy P., and Altmeyer R. Hemagglutinin pseudotyped lentiviral particles: characterization of a new method for avian H5N1 influenza sero-diagnosis. J. Clin. Virol. 39 (2007) 27-33
24. Nicolson C., Major D., Wood J.M., and Robertson J.S. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 23 (2005) 2943-2952
25. Oh S.Y., Cornell B., Smith D., Higgins G., Burrell C.J., and Kok T.W. Rapid detection of Influenza A virus in clinical samples using an ion channel switch biosensor. Biosens. Bioelectron. 23 (2008) 1161-1165
26. Pachucki C.T. Rapid tests for influenza. Curr. Infect. Dis. Rep. 7 (2005) 187-192
27. Peiris J.S.M., de Jong M.D., and Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin. Microbiol. Rev. 20 (2007) 243-267
28. Temperton N.J., Hoschler K., Major D., Nicolson C., Manvell R., Hien V.M., Ha D.Q., de Jong M., Zambon M., Takeuchi Y., and Weiss R.A. A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respiratory Viruses 1 (2007) 105-112
29. Wang W., Butler E.N., Veguilla V., Vassell R., Thomas J.T., Moos Jr. M., Ye Z., Hancock K., and Weiss C.D. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J. Virol. Methods 153 (2008) 111-119
30. Webster R.G., and Govorkova E.A. H5N1 influenza - continuing evolution and spread. N. Engl. J. Med. 355 (2006) 2174-2177
31. Wei C.J., Xu L., Kong W.P., Shi W., Canis K., Stevens J., Yang Z.Y., Dell A., Haslam S.M., Wilson I.A., and Nabel G.J. Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus. J. Virol. 82 (2008) 6200-6208
32. Wiley D.C., Wilson I.A., and Skehel J.J. Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation. Nature 289 (1981) 373-378
33. World Health Organization. Evolution of H5N1 avian influenza viruses in Asia. Emerg. Infect. Dis. 11 (2005) 1515-1521
34. World Health Organization, 2005b. WHO recommendations on the use of rapid testing for influenza diagnosis. July 2005, http://www.who.int/csr/disease/influenza.
35. World Health Organization, 2007. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines. www.who.int, pp. 1-4.
36. Zhao Z.-M., Shortridge K.F., Garcia M., Guan Y., and Wan X.-F. Genotypic diversity of H5N1 highly pathogenic avian influenza viruses. J. Gen. Virol. 89 (2008) 2182-2193